Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion.
Mariana X ByndlossErin E OlsanFabian Rivera-ChávezConnor R TiffanyStephanie A CevallosKristen L Lokken-ToyliTeresa P TorresAustin J ByndlossFranziska FaberYandong GaoYael LitvakChristopher A LopezGege XuEleonora NapoliCecilia GiuliviReneé M TsolisAlexander RevzinCarlito B LebrillaAndreas J BäumlerPublished in: Science (New York, N.Y.) (2017)
Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor γ (PPAR-γ). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-γ signaling. Microbiota-induced PPAR-γ signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward β-oxidation. Therefore, microbiota-activated PPAR-γ signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.
Keyphrases
- microbial community
- nitric oxide synthase
- insulin resistance
- nitric oxide
- multidrug resistant
- pseudomonas aeruginosa
- endothelial cells
- fatty acid
- poor prognosis
- type diabetes
- genome wide
- skeletal muscle
- adipose tissue
- drinking water
- hydrogen peroxide
- urinary tract infection
- ulcerative colitis
- wastewater treatment
- high glucose
- solar cells
- induced pluripotent stem cells